Results 1 to 10 of about 30,153 (204)

Changes in LDL-cholesterol levels following aromatase inhibitor treatment in early postmenopausal breast cancer. [PDF]

open access: yesEur J Epidemiol
Lund M   +8 more
europepmc   +1 more source

24-week home-based walking program in the early adjuvant setting in breast cancer patients who receive aromatase inhibitor endocrine therapy: lessons learned from the SAKK 95/17 WISE prospective, randomized, multicenter trial. [PDF]

open access: yesBreast
Güth U   +17 more
europepmc   +1 more source

OATP1B-type Transport Function Is a Determinant of Aromatase Inhibitor-Associated Arthralgia Susceptibility. [PDF]

open access: yesCancer Res Commun
Taheri H   +16 more
europepmc   +1 more source

The role of exercise in aromatase inhibitor-induced arthralgia. [PDF]

open access: yesPM R
Yu K   +7 more
europepmc   +1 more source

Real-world clinical outcomes associated with first-line palbociclib and aromatase inhibitor therapy among patients with HR+/HER2- advanced breast cancer in Europe. [PDF]

open access: yesBreast Cancer Res Treat
Oikonomidou O   +13 more
europepmc   +1 more source

Role function in postmenopausal women during aromatase inhibitor therapy for breast cancer. [PDF]

open access: yesJ Cancer Surviv
Melnyk H   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy